Institutional shares held 4.99 Million
0 calls
0 puts
Total value of holdings $498M
$0 calls
$0 puts
Market Cap $524M
5,317,270 Shares Out.
Institutional ownership 93.86%
# of Institutions 173


Latest Institutional Activity in MLAB

Top Purchases

Q3 2024
State Street Corp Shares Held: 214K ($21.1M)
Q3 2024
Charles Schwab Investment Management Inc Shares Held: 62.6K ($6.17M)
Q3 2024
Eagle Asset Management Inc Shares Held: 166K ($16.4M)
Q3 2024
Deerfield Management Company, L.P. (Series C) Shares Held: 19.7K ($1.94M)
Q3 2024
Russell Investments Group, Ltd. Shares Held: 74.6K ($7.35M)

Top Sells

Q3 2024
Royce & Associates LP Shares Held: 347K ($34.2M)
Q3 2024
Conestoga Capital Advisors, LLC Shares Held: 529K ($52.2M)
Q3 2024
Janus Henderson Group PLC Shares Held: 78.2K ($7.71M)
Q3 2024
Jane Street Group, LLC Shares Held: 2.31K ($228K)
Q3 2024
Citadel Advisors LLC Shares Held: 10.7K ($1.06M)

About MLAB

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.


Insider Transactions at MLAB

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
30.5K Shares
From 10 Insiders
Exercise of conversion of derivative security 18.9K shares
Grant, award, or other acquisition 11.6K shares
Sell / Disposition
11.3K Shares
From 5 Insiders
Payment of exercise price or tax liability 3.26K shares
Open market or private sale 8.07K shares

Track Institutional and Insider Activities on MLAB

Follow MESA LABORATORIES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MLAB shares.

Notify only if

Insider Trading

Get notified when an Mesa Laboratories Inc insider buys or sells MLAB shares.

Notify only if

News

Receive news related to MESA LABORATORIES INC

Track Activities on MLAB